Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GENNEX LAB. vs PHAARMASIA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GENNEX LAB. PHAARMASIA GENNEX LAB./
PHAARMASIA
 
P/E (TTM) x 34.2 -18.3 - View Chart
P/BV x 4.4 1.8 240.1% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 GENNEX LAB.   PHAARMASIA
EQUITY SHARE DATA
    GENNEX LAB.
Mar-23
PHAARMASIA
Mar-23
GENNEX LAB./
PHAARMASIA
5-Yr Chart
Click to enlarge
High Rs934 26.5%   
Low Rs520 23.8%   
Sales per share (Unadj.) Rs3.440.2 8.3%  
Earnings per share (Unadj.) Rs0.3-1.8 -15.1%  
Cash flow per share (Unadj.) Rs0.3-1.3 -25.1%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs4.515.8 28.7%  
Shares outstanding (eoy) m176.646.83 2,586.2%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.10.7 305.6%   
Avg P/E ratio x25.0-14.8 -168.8%  
P/CF ratio (eoy) x21.0-20.7 -101.6%  
Price / Book Value ratio x1.51.7 88.8%  
Dividend payout %00-   
Avg Mkt Cap Rs m1,229186 659.8%   
No. of employees `000NANA-   
Total wages/salary Rs m7914 558.3%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m593275 215.9%  
Other income Rs m405 766.1%   
Total revenues Rs m633280 226.0%   
Gross profit Rs m47-15 -304.0%  
Depreciation Rs m94 255.3%   
Interest Rs m140 3,008.9%   
Profit before tax Rs m64-14 -445.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m15-2 -839.3%   
Profit after tax Rs m49-13 -390.9%  
Gross profit margin %7.9-5.6 -140.8%  
Effective tax rate %22.812.1 188.8%   
Net profit margin %8.3-4.6 -181.0%  
BALANCE SHEET DATA
Current assets Rs m487150 323.6%   
Current liabilities Rs m295173 170.7%   
Net working cap to sales %32.3-8.2 -396.2%  
Current ratio x1.60.9 189.5%  
Inventory Days Days47 56.7%  
Debtors Days Days57,912,589997 5,807,689.0%  
Net fixed assets Rs m835133 626.7%   
Share capital Rs m18068 263.9%   
"Free" reserves Rs m62340 1,564.9%   
Net worth Rs m804108 743.3%   
Long term debt Rs m1630-   
Total assets Rs m1,322284 466.0%  
Interest coverage x5.7-30.8 -18.5%   
Debt to equity ratio x0.20-  
Sales to assets ratio x0.41.0 46.3%   
Return on assets %4.7-4.3 -110.9%  
Return on equity %6.1-11.6 -52.6%  
Return on capital %8.0-12.8 -62.3%  
Exports to sales %42.10-   
Imports to sales %13.60-   
Exports (fob) Rs m250NA-   
Imports (cif) Rs m81NA-   
Fx inflow Rs m2500-   
Fx outflow Rs m860-   
Net fx Rs m1640-   
CASH FLOW
From Operations Rs m2377 3,642.5%  
From Investments Rs m-383NA 319,408.3%  
From Financial Activity Rs m210-2 -12,903.7%  
Net Cashflow Rs m645 1,343.4%  

Share Holding

Indian Promoters % 23.6 73.5 32.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 0.1 -  
FIIs % 0.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 76.4 26.5 288.4%  
Shareholders   69,723 20,688 337.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GENNEX LAB. With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on GENNEX LABORATORIES vs PHAARMASIA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

GENNEX LABORATORIES vs PHAARMASIA Share Price Performance

Period GENNEX LABORATORIES PHAARMASIA S&P BSE HEALTHCARE
1-Day -0.71% -0.03% 1.22%
1-Month -15.64% -4.59% -0.71%
1-Year 184.04% 19.65% 61.88%
3-Year CAGR 61.67% 5.76% 18.17%
5-Year CAGR 39.51% 12.64% 19.80%

* Compound Annual Growth Rate

Here are more details on the GENNEX LABORATORIES share price and the PHAARMASIA share price.

Moving on to shareholding structures...

The promoters of GENNEX LABORATORIES hold a 23.6% stake in the company. In case of PHAARMASIA the stake stands at 73.5%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of GENNEX LABORATORIES and the shareholding pattern of PHAARMASIA.

Finally, a word on dividends...

In the most recent financial year, GENNEX LABORATORIES paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.

PHAARMASIA paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of GENNEX LABORATORIES, and the dividend history of PHAARMASIA.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine(10:30 am)

Asian markets traded lower, while the US stock indices ended higher overnight with the S&P 500 hitting a record closing high ahead of key economic data.